logo

Anchoring Your Portfolio: Is SGMO Stock a Safe Harbor?

Sangamo Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $3.18 on 11/08/24 and the lowest value was $0.30 on 07/05/24.

52-week price history of SGMO Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Sangamo Therapeutics Inc’s current trading price is -57.38% away from its 52-week high, while its distance from the 52-week low is 345.72%. The stock’s price range during this period has spanned from $0.30 to $3.18. In the Healthcare sector, the Sangamo Therapeutics Inc’s shares surpassed a trading volume of approximately 6.23 million for the day, which was noticeably lower compared to the average daily volume of 9.9.82 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Sangamo Therapeutics Inc (SGMO) has experienced a quarterly rise of 73.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 325.25M and boasts a workforce of 405 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4878, with a change in price of +0.3749. Similarly, Sangamo Therapeutics Inc recorded 7,658,873 in trading volume during the last 100 days, posting a change of +38.45%.

Examining SGMO’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SGMO stands at 0.71. Similarly, the long-term debt-to-equity ratio is also 0.71.

SGMO Stock Stochastic Average

Today, Sangamo Therapeutics Inc’s raw stochastic average for the past 50 days stands at 19.39%, indicating a decline from the raw stochastic average of the last 20 days, which was 22.80%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 18.13% and 12.72% respectively.

SGMO Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 32.84%.However, over the last six months, we can see a weaker performance of 325.57%. Over the last 30 days, the price of SGMO has leaped by -30.15%. And in the last five days, it has fallen by -47.07%.

Most Popular